127 related articles for article (PubMed ID: 34214604)
1. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
Li C; Li H; Zhong H; Li X
J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
[TBL] [Abstract][Full Text] [Related]
2. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
5. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
6. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
Kim Y; Je Y
Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
9. Association Between Pretreatment Blood 25-Hydroxyvitamin D Level and Survival Outcomes in Patients With Clinically Localized Prostate Cancer: An Updated Meta-Analysis.
Cui F; Qiu Y; Xu W; Zou C; Fan Y
Nutr Cancer; 2024; 76(5):395-403. PubMed ID: 38477679
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
11. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
[TBL] [Abstract][Full Text] [Related]
13. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
14. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of serum 25-hydroxyvitamin D in patients with stroke: a meta-analysis.
Liu H; Wang J; Xu Z
J Neurol; 2020 Nov; 267(11):3177-3186. PubMed ID: 31705290
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
18. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis.
Burgaz A; Orsini N; Larsson SC; Wolk A
J Hypertens; 2011 Apr; 29(4):636-45. PubMed ID: 21191311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.
Goodwin PJ; Ennis M; Pritchard KI; Koo J; Hood N
J Clin Oncol; 2009 Aug; 27(23):3757-63. PubMed ID: 19451439
[TBL] [Abstract][Full Text] [Related]
20. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
